1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. NanoViricides Inc (NNVC)
  7. Quote


NanoViricides Stock Price

0.35 (7.76%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 257,746
Bid Price
Ask Price
News -
Day High 4.88


52 Week Range


Day Low 4.48
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NanoViricides Inc NNVC AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.35 7.76% 4.86 17:00:00
Open Price Low Price High Price Close Price Prev Close
4.78 4.48 4.88 4.86 4.51
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
790 257,746 $ 4.73 $ 1,218,967 - 2.85 - 8.71
Last Trade Time Type Quantity Stock Price Currency
17:00:00 1,416 $ 4.86 USD


Draw Mode:

NanoViricides Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 56.01M 11.53M 10.93M $ - $ - -0.81 -5.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 36.70%

more financials information »

NanoViricides News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NNVC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.685.194.124.39236,8110.183.85%
1 Month4.885.564.124.78206,194-0.02-0.41%
3 Months4.057.863.775.712,793,1880.8120.0%
6 Months3.337.863.335.561,457,2051.5345.95%
1 Year3.838.712.855.851,407,5471.0326.89%
3 Years0.3519.800.160457.231,085,8824.511,288.57%
5 Years1.3119.800.160456.82701,6423.55270.99%

NanoViricides Description

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.